India has commenced paediatric trials for Covaxin, its indigenously-manufactured vaccine against COVID-19. Covaxin, manufactured by Hyderabad-based firm Bharat Biotech, is one of four vaccines authorised for use in India alongside Covishield (produced by the Serum Institute of India on license from AstraZeneca), the Russian-manufactured Sputnik-V, and the Moderna vaccine. Bharat Biotech announced last month that …
The Moderna vaccine is to become available in India by July 15th, reports indicate. Cipla, a pharmaceutical firm based in Mumbai, received the nod to import doses of the Moderna vaccine from the Drug Controller General of India (DCGI) last month. It became the fourth COVID-19 vaccine to receive emergency use authorisation from the Centre …
The Pfizer/BioNTech vaccine against COVID-19 has registered a lower level of efficacy in preventing the Delta variant first identified in India, according to new data from Israel. Effectiveness of the vaccine has dropped to 64 percent in preventing infection as the Delta variant spreads in Israel, now accounting for ninety percent of the country’s cases. …
Pfizer/BioNTech vaccine: Less effective against Delta variant? Read More »
Heatwaves in India claimed more than 17,000 lives in a near half-century, research published earlier this year has found. The trend of heatwave deaths points to the rising urgency of combating climate change. Between 1971 and 2019, the research posited that extreme weather events claimed 141,308 lives. Of these fatalities, twelve percent – translating to …
The number of COVID-19 vaccinations administered in India has surpassed 35 crore, according to the Union Ministry of Health and Family Welfare. This marks a shot in the arm for vaccination coverage in a country hard-hit by the pandemic where such coverage has been lagging. In a statement released yesterday, the Ministry said 351,221,306 doses …
The World Health Organization (WHO) announced in its weekly epidemiological update that the so-called Delta variant is present in 96 countries. This marks an increase of eleven countries where the Delta variant has been detected compared to last week. First identified in India, the Delta variant is considered to be more transmissible. It has been …
A recent World Health Organization (WHO) press release has revealed a set of key principles for determining how best to utilise artificial intelligence (AI) within the context of healthcare, along with the challenges it may present. The report, “Ethics and governance of artificial intelligence for health”, is the result of two years of consultations held …
India is seeking approval from the European Medicines Agency (EMA) for Covishield, one of its COVID-19 vaccines. Covisheld approval is being sought on an emergency authorisation basis from the bloc’s apex medical regulatory body. The Serum Institute of India (SII) manufactures Covishield, which is the Indian variant so to speak of the COVID-19 vaccine produced …
Recently, Health Issues India had the opportunity to interview Mr Akansh Khurana, co-founder, and chief executive officer, of THB. THB (short for Technology, Healthcare, and Big Data Analytics), formerly known as “The Healthy Billion”, was founded by Akansh Khurana, Rajesh Pachar, and Rohit Kumar in 2015 to drive clinical insights and research that enables positive patient …
Exclusive interview: THB co-founder and CEO Akansh Khurana Read More »
Following the success stories of the Pfizer and Moderna mRNA vaccines for COVID-19, many thought mRNA vaccines paved the way for the future of immunisation. These theories may be faced with a setback as phase-III trials of fellow mRNA vaccine candidate CureVac has achieved subpar results. CureVac, based in Tübingen, Germany, announced data from the …
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
